Small molecule tyrosine kinase inhibitors of ErbB2/HER2/Neu in the treatment of aggressive breast cancer.
about
Identifying network biomarkers based on protein-protein interactions and expression data.Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumabStructure-based Design of Peptides with High Affinity and Specificity to HER2 Positive TumorsOptical Screening of Female Breast Cancer from Whole Blood Using Raman Spectroscopy.Discovery of a Potential HER2 Inhibitor from Natural Products for the Treatment of HER2-Positive Breast CancerDesign and Synthesis of Near-Infrared Peptide for in Vivo Molecular Imaging of HER2Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer.Detection of new human metabolic urinary markers in chronic alcoholism and their reversal by aqueous extract of Tinospora cordifolia stem.Protein Kinase Targets in Breast Cancer.In vivo loss-of-function screens identify KPNB1 as a new druggable oncogene in epithelial ovarian cancer.Predicting the Efficacy of HER2-Targeted Therapies: A Look at the Host.Neratinib: First Global Approval.Blood HER2 and Uromodulin as Causal Mediators of CKD.DNA Mutations May Not Be the Cause of Cancer.Activation of Neuregulin 1/ErbB Signaling Is Involved in the Development of TOCP-Induced Delayed Neuropathy.Microscopes and Mass Spectrometers.A combined approach with gene-wise normalization improves the analysis of RNA-seq data in human breast cancer subtypes
P2860
Q30965908-59B2CBE2-567C-477B-833E-D1B2D89C7EADQ35209810-065AE9C7-479E-49B1-A582-D43B7DB6EF27Q35942583-CCD11055-769B-4043-B004-E577DDAC35CFQ36135290-C07E9A44-F1F2-4613-8365-5721BDA1054EQ37134449-1D217FC6-CA5C-4DC5-B7A3-F171F71AE09CQ37741398-FF0BDF7C-7BCE-4EB9-B5F0-FC689B25DA74Q38434942-2EDF56F3-22B7-40D3-B5ED-BC2F4A5CE650Q41261444-E77FE424-AC84-41D9-819D-F57FE4A5AD2AQ47351355-77D38B7C-2F56-48AF-9665-DA0A4C42419EQ47948390-3DE6778E-C479-47CB-8BDA-6ABA8FCE3263Q48102534-D152C13C-74E9-4AC1-930A-20DB391EAE7CQ50201250-F172A3C8-2477-4E50-9F00-2B2C2BB228DBQ51743726-355F4B6D-C3A4-45BF-85BF-58FD2FACA5CEQ53725947-635D260B-8E3A-464A-B19A-F41741EE1139Q55191633-2E6D53CD-6872-47E3-AB7D-C8A123C091A3Q55340944-7D8DB875-72E9-46EE-BDA2-046C9E89F434Q58796166-2B439783-2990-429A-B34A-1B23C61FEA3C
P2860
Small molecule tyrosine kinase inhibitors of ErbB2/HER2/Neu in the treatment of aggressive breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Small molecule tyrosine kinase ...... t of aggressive breast cancer.
@en
type
label
Small molecule tyrosine kinase ...... t of aggressive breast cancer.
@en
prefLabel
Small molecule tyrosine kinase ...... t of aggressive breast cancer.
@en
P2860
P1433
P1476
Small molecule tyrosine kinase ...... nt of aggressive breast cancer
@en
P2093
Cheryl L Stevens
Jayalakshmi Sridhar
P2860
P304
15196-15212
P356
10.3390/MOLECULES190915196
P407
P577
2014-09-23T00:00:00Z